Pancreatic Cell News Volume 12.04 | Feb 2 2021

    0
    49







    2021-02-2 | PACN 7.04


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 12.04 – 2 February, 2021
    TOP STORY

    Inceptor Counteracts Insulin Signaling in β-Cells to Control Glycaemia

    The authors identified an inhibitor of insulin receptor and IGF1 receptor signaling in mouse β-cells, which they named the insulin inhibitory receptor.
    [Nature]

    AbstractPress Release

    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    PUBLICATIONSRanked by the impact factor of the journal

    PDX1LOW MAFALOW β-Cells Contribute to Islet Function and Insulin Release

    Investigators showed that subtle differences in β-cell maturity, defined using PDX1 and MAFA expression, contributed to islet operation.
    [Nature Communications]

    Full ArticlePress Release

    Chromatin 3D Interaction Analysis of the STARD10 Locus Unveils FCHSD2 as a Regulator of Insulin Secretion

    Using chromatin conformation capture, researchers showed that an enhancer cluster in the STARD10 type 2 diabetes locus forms a defined 3D chromatin domain.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Pancreatic Beta Cell Autophagy Is Impaired in Type 1 Diabetes

    Scientists hypothesized that beta cell autophagy was dysfunctional in type 1 diabetes and that there was a progressive loss during early diabetes development.
    [Diabetologia]

    Full ArticleGraphical Abstract

    Pericytes Contribute to the Islet Basement Membranes to Promote Beta-Cell Gene Expression

    Investigators showed that pericytes produced multiple components of the mouse pancreatic and islet interstitial and basement membrane matrices.
    [Scientific Reports]

    Full Article

    IL17A Critically Shapes the Transcriptional Program of Fibroblasts in Pancreatic Cancer and Switches on Their Protumorigenic Functions

    The authors investigated the role of interleukin-17A (IL17A) and its effect on tumor fibroblasts and the tumor microenvironment. They used a spontaneous PDAC mouse model crossed to IL17A knockout mice to show an extensive desmoplastic reaction, without impaired immune infiltration.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Autophagy Is Required for Proper Cysteine Homeostasis in Pancreatic Cancer through Regulation of SLC7A11

    Researchers demonstrated that under nutrient-replete conditions, loss of autophagy in PDAC led to a relatively restricted impairment of amino acid pools, with cysteine levels showing a significant drop.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    SHCBP1 Interacting with EOGT Enhances O-GlcNAcylation of NOTCH1 and Promotes the Development of Pancreatic Cancer

    Scientists hypothesized that SHCBP1 and O-linked GlcNAc transferase (EOGT) could mediate PDAC progression by influencing NOTCH1 O-GlcNAcylation.
    [Genomics]

    Abstract

    c-Jun N-Terminal Kinase 2 Suppresses Pancreatic Cancer Growth and Invasion and Is Opposed by c-Jun N-Terminal Kinase 1

    Human pancreatic cancer cell lines MIA PaCa-2 and PANC-1 clones were established either expressing either JNK1 or -2 shRNA in a stable manner.
    [Cancer Gene Therapy]

    Full Article

    Enhanced Anticancer Potency of Hydroxytyrosol and Curcumin by PLGA-PAA Nano-Encapsulation on PANC-1 Pancreatic Cancer Cell Line

    Researchers investigated the anti‐cancer function of free and nano‐encapsulated hydroxytyrosol and curcumin, and their combinations on the PANC‐1 cell line.
    [Environmental Toxicology]

    Abstract

    Explore scientific events this February with the Science Events Calendar.
    REVIEWS

    Immune Dysfunction in Developmental Programming of Type 2 Diabetes Mellitus

    Several activated immune pathways have been identified in the islets of people who experienced itrauterine growth restriction, with alternations in the levels of IL-1β and IL-4 as well as changes in TGFβ signaling. Leptin levels are also altered.
    [Nature Reviews Endocrinology]

    Abstract

    Engineering Biopharmaceutical Formulations to Improve Diabetes Management

    The authors highlight the advantages and limitations of recent advances in drug formulation that improve protein stability and pharmacokinetics, prolong drug delivery, or enable alternative dosage forms for the management of diabetes.
    [Science Translational Medicine]

    Abstract

    INDUSTRY AND POLICY NEWS

    Interpace Biosciences Announces License Agreement with Rutgers University and Mass General Hospital

    Interpace Biosciences, Inc. announced that it has executed a license agreement with Rutgers, the State University of New Jersey, and Massachusetts General Hospital for a novel monoclonal antibody platform, Das-1, used in the risk assessment of pancreatic cysts.
    [Interpace Biosciences, Inc.]

    Press Release

    Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes (T1D)

    Vertex Pharmaceuticals, Incorporated announced that the FDA has cleared the IND, enabling the company to proceed with initiating a clinical trial for VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell therapy to treat T1D.
    [Vertex Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    Stanford Diabetes Research Center: Insulin 100th Birthday Celebration

    February 18, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postodctoral Researcher – Molecular Cardiology

    Karolinska Institutet – Stockholm, Sweden

    Scientist – Metabolism Research

    Weill Cornell Medicine – New York, New York, United States

    Associate / Senior Editor – Nature Reviews Endocrinology

    Nature Reviews Endocrinology – London, England, United Kingdom

    Postdoctoral Fellow Positions – Penn Epigenetics Institute

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    Research Fellow – Molecular Metabolism

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter